J
Jessica Davies
Researcher at University College London
Publications - 10
Citations - 721
Jessica Davies is an academic researcher from University College London. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 4 publications receiving 218 citations.
Papers
More filters
Journal ArticleDOI
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection.
Laura J. Pallett,Jessica Davies,Emily J. Colbeck,Francis P. Robertson,N. Hansi,Nicholas Easom,Alice R Burton,Kerstin A. Stegmann,Anna Schurich,Leo Swadling,Upkar S. Gill,Victoria Male,Tu Vinh Luong,Amir Gander,Brian R. Davidson,Patrick T F Kennedy,Mala K. Maini +16 more
TL;DR: It is suggested that inhibitory molecules, together with paradoxically robust, rapid, cell-autonomous IL-2 and IFN&ggr; production, equip liver CD8 TRM to survive while exerting local noncytolytic hepatic immunosurveillance.
Journal ArticleDOI
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Leo Swadling,Mariana O. Diniz,Nathalie M. Schmidt,Oliver E. Amin,Aneesh Chandran,Emily Shaw,Corinna Pade,Joseph M Gibbons,Nina Le Bert,Anthony T. Tan,Anna Jeffery-Smith,Anna Jeffery-Smith,Cedric C.S. Tan,Christine Y.L. Tham,Stephanie Kucykowicz,Gloryanne Aidoo-Micah,Joshua Rosenheim,Jessica Davies,Marina Johnson,Melanie P. Jensen,Melanie P. Jensen,George Joy,George Joy,Laura E. McCoy,Ana M. Valdes,Ana M. Valdes,Benjamin M. Chain,David Goldblatt,Daniel M. Altmann,Rosemary J. Boyton,Rosemary J. Boyton,Charlotte Manisty,Charlotte Manisty,Thomas A. Treibel,Thomas A. Treibel,James C. Moon,James C. Moon,Lucy van Dorp,Francois Balloux,Áine McKnight,Mahdad Noursadeghi,Antonio Bertoletti,Antonio Bertoletti,Mala K. Maini +43 more
TL;DR: In this paper, the authors measured SARS-CoV-2-reactive T-cells, including those against the early transcribed replication transcription complex (RTC) in intensively monitored healthcare workers (HCW), remaining repeatedly negative by PCR, antibody binding, and neutralization (seronegative HCW, SN-HCW).
Posted ContentDOI
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection
Leo Swadling,Mariana O. Diniz,Nathalie M. Schmidt,Oliver E. Amin,Aneesh Chandran,Emily Shaw,Corinna Pade,Joseph M Gibbons,Nina Le Bert,Anthony T. Tan,Christine Y.L. Tham,Cedric C.S. Tan,Stephanie Kucyowicz,Gloryanne Aidoo-Micah,Joshua Rosenheim,Jessica Davies,Melanie P. Jensen,George Joy,Laura E. McCoy,Ana M. Valdes,Lucy van Dorp,Daniel M. Altmann,Rosemary J. Boyton,Charlotte Manisty,Thomas A. Treibel,James C. Moon,COVIDsortium Investigators,COVIDsortium Investigators,Francois Balloux,Áine McKnight,Mahdad Noursadeghi,Antonio Bertoletti,Mala K. Maini +32 more
TL;DR: In this article, the authors showed that the RNA-polymerase within RTC was the largest region of high sequence conservation across human seasonal coronaviruses (HCoV) and was preferentially targeted by T cells from UK and Singapore pre-pandemic cohorts and from ES.
Journal ArticleDOI
Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators.
Oliver E. Amin,Emily J. Colbeck,Stephane Daffis,Shahzada Khan,Dhivya Ramakrishnan,Divya Pattabiraman,Ruth Chu,Holly Micolochick Steuer,Sophie Lehar,Leanne Peiser,Adam Palazzo,Christian R. Frey,Jessica Davies,Hassan Javanbakht,William Rosenberg,Simon P. Fletcher,Mala K. Maini,Laura J. Pallett +17 more
TL;DR: In this paper, GS-9688 (selgantolimod) is used to boost responses contributing to viral control and to modulate regulatory mediators in chronic hepatitis B (CHB).
Journal ArticleDOI
NK cells limit therapeutic vaccine–induced CD8+T cell immunity in a PD-L1–dependent manner
Mariana O. Diniz,Anna Schurich,Senthil Chinnakannan,Marion Duriez,Kerstin A. Stegmann,Jessica Davies,Stephanie Kucykowicz,Kornelija Suveizdyte,Oliver E. Amin,Frances Alcock,Tamsin Cargill,Eleanor Barnes,Mala K. Maini +12 more
TL;DR: Manipulating NK cell calibration of T cells enhances therapeutic adenoviral vector vaccination immunogenicity in chronic HBV infection.